CLL-390 Persistence and Time to Next Treatment With Ibrutinib Treatment in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Including Patients at High Risk for Atrial Fibrillation or Stroke: A Real-World Study
- Resource Type
- Source
- Clinical Lymphoma Myeloma and Leukemia. 22:S276-S277
- Subject
Cancer Research Oncology Hematology - Language
- ISSN
- 2152-2650